Impax Archives - CDR – Chain Drug Review

Kaleo set to bring back Auvi-Q epinephrine injector

October 26, 2016 by Chain Drug Review anaphylaxis, Auvi-Q, epinephrine auto-injector, EpiPen, Eric Edwards, Evan Edwards, generic epinephrine auto-injector, Impax, Kaleo, mylan, Spencer Williamson, video Leading Headlines, Pharmacy, Supplier News, Videos

RICHMOND, Va. — Pharmaceutical company Kaleo plans to reintroduce the Auvi-Q epinephrine auto-injector to the U.S. market in the first half of 2017. For emergency use in treating life-threatening allergic reactions such as anaphylaxis, Auvi-Q is expected to provide an option to the EpiPen from Mylan Inc., which has been lambasted by government officials, the

Impax to introduce Adderall XR generic

February 17, 2016 by Chain Drug Review ADHD, attention deficit hyperactivity disorder, Fred Wilkinson, generic version of Adderall XR, Impax, mixed amphetamine Pharmacy, Supplier News

HAYWARD, Calif. — Impax Laboratories Inc. has received Food and Drug Administration approval for dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules, mixed amphetamine product used for the treatment of attention deficit hyperactivity disorder (ADHD). Impax said Wednesday that its mixed amphetamine product, a CII controlled substance, comes in dosages of